Etra, A., El Jurdi, N., Katsivelos, N., Kwon, D., Gergoudis, S., Morales, G., Spyrou, N., Kowalyk, S., Aguayo-Hiraldo, P., Akahoshi, Y., Ayuk, F., Baez, J., Betts, B. C., Chanswangphuwana, C., Chen, Y.-B., Choe, H., DeFilipp, Z., Gleich, S., Hexner, E., … Holtan, S. (2024). Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD. Blood Advances, 8(12), 3284–3292. https://doi.org/10.1182/bloodadvances.2023011049

Xu-Monette, Z. Y., Wei, L., Fang, X., Au, Q., Nunns, H., Nagy, M., Tzankov, A., Zhu, F., Visco, C., Bhagat, G., Dybkaer, K., Chiu, A., Tam, W., Zu, Y., Hsi, E. D., Hagemeister, F. B., Sun, X., Han, X., Go, H., … Young, K. H. (2022). Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. Clinical Cancer Research, 28(5), 972–983. https://doi.org/10.1158/1078-0432.ccr-21-2949